|
2025
|
Invention
|
Compound for use in methods for treatment of polycystic kidney disease. Provided herein are metho... |
|
|
Invention
|
Compositions for treatment of polycystic kidney disease.
Provided herein are methods for the tre... |
|
|
Invention
|
Methods and compositions for treatment of polycystic kidney disease.
Provided herein are methods... |
|
2024
|
Invention
|
Modified oligonucleotide for treating polycystic kidney disease. Provided herein are methods for ... |
|
|
Invention
|
Methods for treating nervous system disorders. Provided herein are methods for the treatment of a... |
|
2023
|
Invention
|
Methods for treatment of polycystic kidney disease.
Provided herein are methods for the treatmen... |
|
2022
|
Invention
|
Methods and compositions for avoiding off-target effects.
Provided herein are compounds comprisi... |
|
|
Invention
|
Methods and compositions for avoiding off-target effects. Provided herein are compounds comprisin... |
|
|
Invention
|
Methods and compositions for treatment of polycystic kidney disease. Provided herein are methods ... |
|
|
G/S
|
Oligonucleotide preparations for therapeutic pharmaceutical purposes for a wide variety of condit... |
|
2020
|
Invention
|
Microrna compounds and methods for modulating mir-122.
Described herein are compositions and met... |
|
|
Invention
|
Modified oligonucleotides for treatment of polycystic kidney disease.
Provided herein are method... |
|
|
G/S
|
oligonucleotide preparations for therapeutic pharmaceutical purposes for a wide variety of condit... |
|
|
Invention
|
Methods for treatment of polycystic kidney disease. Provided herein are methods for the treatment... |
|
2019
|
Invention
|
Microrna compounds and methods for modulating mir-10b activity.
Described herein are composition... |
|
|
Invention
|
Microrna compounds and methods for modulating mir-10b activity. Described herein are compositions... |
|
|
Invention
|
Methods for oral delivery of oligonucleotides.
Provided herein are methods for oral administrati... |
|
|
Invention
|
Methods for oral delivery of oligonucleotides. Provided herein are methods for oral administratio... |
|
|
Invention
|
Galnac conjugated modified oligonucleotides as mir-122 inhibitor having hcv antiviral activity wi... |
|
|
Invention
|
Galnac conjugated modified oligonucleotide as mir-122 inhibitor having hcv antiviral activity wit... |
|
|
Invention
|
Compounds and methods for enhanced cellular uptake. Described herein are conjugated modified olig... |
|
2018
|
Invention
|
Targeting micrornas for metabolic disorders.
Described herein are compounds comprising modified ... |
|
|
Invention
|
Oligomeric compounds and compositions for use in modulation of small non-coding rnas. Compounds, ... |
|
|
Invention
|
Methods for treatment of alport syndrome. Provided herein are methods for the treatment of Alport... |
|
|
Invention
|
Targeting micrornas for the treatment of fibrosis.
Provided herein are compositions and methods ... |
|
2017
|
Invention
|
Modified oligonucleotides for treatment of polycystic kidney disease. Provided herein are methods... |
|
|
Invention
|
Targeting micrornas for the treatment of liver cancer. Provided herein are methods for the treatm... |
|
|
Invention
|
Targeting micrornas for metabolic disorders. Described herein are compounds comprising modified o... |
|
|
G/S
|
Oligonucleotide preparations for therapeutic pharmaceutical purposes Research and development of ... |
|
|
Invention
|
Microrna compounds and methods for modulating mir-122. Described herein are compositions and meth... |
|
2016
|
Invention
|
Targeting micrornas for the treatment of fibrosis. Provided herein are compositions and methods f... |
|
|
Invention
|
Systems, compositions, and methods for formulating nucleic acid compositions. Provided herein are... |
|
|
Invention
|
Methods for direct measurement of microrna inhibition and mimicry.
The disclosure includes metho... |
|
|
Invention
|
Methods for direct measurement of microrna inhibition and mimicry. The disclosure includes method... |
|
|
Invention
|
Non-alcoholic fatty liver disease biomarkers.
Methods, compositions, kits, and systems for chara... |
|
2008
|
G/S
|
Pharmaceuticals. Educational and information materials in the field of pharmaceuticals. Informati... |
